Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin in peritoneal dialysis patients with end-stage type 2 diabetic nephropathy
ChiCTR-TRC-14004150Phase 4Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sitagliptin in type 2 diabetes mellitus (T2DM) and diabetic glomerulosclerosis (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: HbA1c, glycated albumin and 4 more. Started Jan 2014; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-14004150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004150.